SCHEMBL28631641

SCHEMBL28631641

COc1cc(-c2nn(C)c(N)c2-c2ccc(SC)cc2)cc(OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP1B1 Q16678 1/20 0.43
▸ MAPK14 Q16539 1/20 0.42
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ ABL1 P00519 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ HCK P08631 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ EPHB4 P54760 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ PI4KB Q9UBF8 1/20 0.39
▸ TUBB4A P04350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28612774 0.86 TUBB4A (0.49) MAPK14SRCKDRTUBB4ATUBB
SCHEMBL28616407 0.85 RIPK2 (0.44) CYP1A1CYP1A2CYP1B1CA1CA2
SCHEMBL28624086 0.83 SRC (0.53) CYP1A1CYP1A2CYP1B1SRCKDR
SCHEMBL28614006 0.82 BRAF (0.54) CYP1A1CYP1A2CYP1B1MAPK14EGFR
SCHEMBL28627247 0.81 TUBB4A (0.48) MAPK14PIK3CDABL1EGFRHCK
SCHEMBL28921643 0.81 PAX8 (0.47) MAPK14TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20821458 0.73 CYP1A1 (0.62) CYP1A1CYP1A2CYP1B1CA1CA2
SCHEMBL28234764 0.73 PIK3CD (0.42) PIK3CDABL1EGFRHCKSRC
SCHEMBL28631644 0.73 CHEK1 (0.38) PIK3CDABL1EGFRHCKSRC
SCHEMBL28616736 0.72 SRC (0.60) SRCKDRTUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108409663-B Microtubule inhibitors, methods of preparation and uses thereof 成都威斯克生物医药有限公司 2021-09-03 — — CN disclosed
Send feedback